Approval · Notice of Compliance 10796 · 2009
ELOINE: Notice of Compliance 10796
Issued November 24, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10796
- Date
- November 24, 2009
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Oral contraceptive / Acne therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELOINE | 02337681 | — |
Medicinal ingredients
- DROSPIRENONE 3 MG per TAB
- ETHINYL ESTRADIOL 0.02 MG per TAB